Early research (Phase 1)Study completedNCT01705847What this trial is testingA Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid MalignanciesWho this might be right forLymphoid Malignancies Gilead Sciences 39
Testing effectiveness (Phase 2)WithdrawnNCT01415765What this trial is testingMLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaWho this might be right forLymphoma, Diffuse Large-Cell B-cellDiffuse, Large B-cell LymphomaLymphoma, Diffuse Large-Cell+1 more National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT05144347What this trial is testingStudy of XL114 in Subjects With Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma (NHL)Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)Mantle Cell Lymphoma (MCL)+2 more Exelixis 2
Early research (Phase 1)Looking for participantsNCT07691606What this trial is testingARC-02 in B-cell NHLWho this might be right forB-cell Non Hodgkin Lymphoma Taiho Oncology, Inc. 140
Early research (Phase 1)Study completedNCT02112526What this trial is testingAcalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell LymphomaWho this might be right forActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL) Acerta Pharma BV 21
Large-scale testing (Phase 3)Study completedNCT02285062What this trial is testingEfficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell LymphomaWho this might be right forLymphoma, Large B-Cell, Diffuse Celgene 570
Early research (Phase 1)Active Not RecruitingNCT06667687What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma AbbVie 21